Navigation Links
Global Melanoma Therapeutics Market 2012-2016
Date:10/29/2013

London (PRWEB) October 29, 2013

TechNavio analysts forecast the Global Melanoma Therapeutics market to grow at a CAGR of 15.83 percent over the period 2012-2016. One of the key factors contributing to this market growth is the availability of new promising drugs in the pipeline. The Global Melanoma Therapeutics market has also been witnessing the increasing use of combination therapies for the treatment of melanoma. However, the availability of alternative treatment options could pose a challenge to the growth of this market.

TechNavio's report, the Global Melanoma Therapeutics market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Global Melanoma Therapeutics market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

The key vendors dominating this market space are Bristol-Myers Squibb Co., Merck and Co. Inc., and F. Hoffmann-La Roche Ltd.

The Other vendors mentioned in the report are AB Science S.A., Amgen Inc., Celgene Corp., Daiichi Sankyo Co., Eisai Co. Ltd., GlaxoSmithKline plc, Pfizer Inc., and Vical Inc.

Key questions answered in this report:
What will the market size be in 2016 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

Methodology

Research methodology is based on extensive primary and secondary research. Primary research includes in-depth interviews with industry experts, vendors, resellers and customers. Secondary research includes Technavio Platform, industry publications, company reports, news articles, analyst reports, trade associations and the data published by Government agencies.

1. Executive Summary
2. List of Abbreviations
3. Introduction
4. Market Research Methodology
Market Research Process
Research Design
Research Methodology
5. Scope of the Report
Market Overview
Product Offerings
6. Market Landscape
Market Size and Forecast
6.1. Five Force Analysis
7. Melanoma Therapeutics Drugs in Pipeline
8. Geographical Segmentation
9. Vendor Landscape
10. Buying Criteria
11. Market Growth Drivers
12. Drivers and their Impact
13. Market Challenges
14. Impact of Drivers and Challenges
15. Market Trends
16. Key Vendor Analysis
16.1. Bristol-Myers Squibb Co.
16.1.1. Business Overview
16.1.2. Key Information
16.1.3. SWOT Analysis
16.2. F. Hoffmann-La Roche Ltd.
16.2.1. Business Overview
16.2.2. Business Segmentation
16.2.3. Key Information
16.2.4. SWOT Analysis
16.3. Merck & Co. Inc.
16.3.1. Business Overview
16.3.2. Business Segmentation
16.3.3. Key Information
16.3.4. SWOT Analysis
17. Other Reports in this Series

List of Exhibits:

Exhibit 1: Market Research Methodology
Exhibit 2: Global Melanoma Therapeutics Market 2012-2016 (US$ million)
Exhibit 3: Global Melanoma Therapeutics Market by Geographical Segmentation 2012
Exhibit 4: Global Melanoma Therapeutics Market by Vendor Segmentation 2012
Exhibit 5: Business Segmentation of F. Hoffmann-La Roche Ltd.
Exhibit 6: Business Segmentation of Merck and Co. Inc.

Read the full report:

Global Melanoma Therapeutics Market 2012-2016

http://www.reportbuyer.com/pharma_healthcare/treatments/global_melanoma_therapeutics_market_2012_2016_2.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Therapy

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com
Tel: +44 208 816 85 48
Website: http://www.reportbuyer.com/

Read the full story at http://www.prweb.com/releases/2013/10/prweb11279607.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Global Dental Implants Market 2012-2016
2. Global Green (Sustainable) Packaging Market 2012-2016
3. Facial Injectables Industry 2013 Global Analysis in New Report at MaretReportsOnline.com
4. BCC Research Publishes A New Report On Global Markets For Telemedicine Technologies
5. Global Survey Shows Personal Mobile Computing Devices Growing Into a Major Cyber Security Concern
6. Antibiotic Resistance 2013: A Global Market Study
7. Congenital Heart Disease Global Clinical Trials Review, H2, 2013
8. Pregnancy Global Clinical Trials Review, H2, 2013
9. General Anxiety Disorder Global Clinical Trials Review, H2, 2013
10. Vi Tour Experience - Body By Vi Dream Team Behind the Scenes at Vi Global Headquarters
11. ExactTarget Presents Global Services Award to ListEngage
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... ... Restoration, has recently contributed a medical article to the newly revamped Cosmetic ... Mohebi’s article spotlights the hair transplant procedure known as Follicular Unit Extraction ...
(Date:10/12/2017)... , ... October 12, 2017 , ... Leading pediatric oncology ... in Washington, D.C., for the 49th Congress of the International Society of Paediatric ... President of the Center for Cancer and Blood Disorders at Children’s National, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned ... Michigan’s 2017 Best and Brightest in Wellness® by Best and Brightest. OnSite Wellness ... on Friday, Oct. 20 from 7:30 a.m. to 2 p.m. at the Henry ...
(Date:10/12/2017)... ... October 12, 2017 , ... In ... taxes a year. In some states—like New York, New Jersey, Massachusetts, Texas, Virginia, ... overseas retirement havens have extremely low property-tax rates, which contributes to the relatively ...
(Date:10/12/2017)... ... October 12, 2017 , ... Farm Forward ... and other leading institutions in announcing the launch of the Leadership Circle ... way animals are raised for food. , Founding members of the Leadership Circle ...
Breaking Medicine News(10 mins):
(Date:9/22/2017)... -- AVACEN Medical (AVACEN) announced that its CE-Marked AVACEN ... with the widespread pain associated with fibromyalgia in the ... Essex, England commented, "I had difficulty ... sleep at all, tremendous pain, with every movement sending ... AVACEN 100] enough, how this has and is helping ...
(Date:9/18/2017)... PROVIDENCE, R.I. , Sept. 18, 2017 ... in the fields of bioinformatics and immune ... to develop a protective avian influenza A (H7N9) vaccine. ... is distantly related to seasonal influenza and ... approaches, which rely on prior exposure to be ...
(Date:9/12/2017)... , Sept. 12, 2017  ValGenesis Inc., ... Solutions (VLMS), is pleased to announce the appointment ... member of its Board of Directors and Chairman ... VLMS enables life science companies to manage their ... use of paper in this process. Furthermore, ValGenesis ...
Breaking Medicine Technology: